Noh DY - Search Results

1

Clinical significance of annexin A1 expression in breast cancer.

Yom CK, Han W, Kim SW, Kim HS, Shin HC, Chang JN, Koo M, Noh DY, Moon BI. Yom CK, et al. Among authors: noh dy. J Breast Cancer. 2011 Dec;14(4):262-8. doi: 10.4048/jbc.2011.14.4.262. Epub 2011 Dec 27. J Breast Cancer. 2011. PMID: 22323911 Free PMC article.

2

Polymorphisms in the estrogen receptor-alpha gene and breast cancer risk.

Kang HJ, Kim SW, Kim HJ, Ahn SJ, Bae JY, Park SK, Kang D, Hirvonen A, Choe KJ, Noh DY. Kang HJ, et al. Among authors: noh dy. Cancer Lett. 2002 Apr 25;178(2):175-80. doi: 10.1016/s0304-3835(01)00861-8. Cancer Lett. 2002. PMID: 11867202

3

Identification of angiogenesis in primary breast carcinoma according to the image analysis.

Kim SW, Park SS, Ahn SJ, Chung KW, Moon WK, Im JG, Yeo JS, Chung JK, Noh DY. Kim SW, et al. Among authors: noh dy. Breast Cancer Res Treat. 2002 Jul;74(2):121-9. doi: 10.1023/a:1016150213253. Breast Cancer Res Treat. 2002. PMID: 12186372 Clinical Trial.

4

Phospholipase C-protein kinase C mediated phospholipase D activation pathway is involved in tamoxifen induced apoptosis.

Ahn SJ, Yoon MS, Hyuk S, Han W, Yoon YD, Han JS, Noh DY. Ahn SJ, et al. Among authors: noh dy. J Cell Biochem. 2003 Jun 1;89(3):520-8. doi: 10.1002/jcb.10532. J Cell Biochem. 2003. PMID: 12761885

5

hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women.

Choi JY, Hamajima N, Tajima K, Yoo KY, Yoon KS, Park SK, Kim SU, Lee KM, Noh DY, Ahn SH, Choe KJ, Han W, Hirvonen A, Kang D. Choi JY, et al. Among authors: noh dy. Breast Cancer Res Treat. 2003 May;79(1):59-62. doi: 10.1023/a:1023305826726. Breast Cancer Res Treat. 2003. PMID: 12779082 Clinical Trial.

6

Estrogen receptor alpha gene polymorphisms and breast cancer risk.

Shin A, Kang D, Nishio H, Lee MJ, Park SK, Kim SU, Noh DY, Choe KJ, Ahn SH, Hirvonen A, Kim JH, Yoo KY. Shin A, et al. Among authors: noh dy. Breast Cancer Res Treat. 2003 Jul;80(1):127-31. doi: 10.1023/a:1024439202528. Breast Cancer Res Treat. 2003. PMID: 12889606

7

Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features.

Han W, Kang D, Park IA, Kim SW, Bae JY, Chung KW, Noh DY. Han W, et al. Among authors: noh dy. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):124-30. doi: 10.1158/1078-0432.ccr-0834-3. Clin Cancer Res. 2004. PMID: 14734460

8

Full sequencing analysis of estrogen receptor-alpha gene polymorphism and its association with breast cancer risk.

Han W, Kang D, Lee KM, Kim HJ, Ahn SJ, Kim SW, Chung KW, Lee ES, Noh DY. Han W, et al. Among authors: noh dy. Anticancer Res. 2003 Nov-Dec;23(6C):4703-7. Anticancer Res. 2003. PMID: 14981916

9

Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women.

Lee SA, Kang D, Nishio H, Lee MJ, Kim DH, Han W, Yoo KY, Ahn SH, Choe KJ, Hirvonen A, Noh DY. Lee SA, et al. Among authors: noh dy. Exp Mol Med. 2004 Apr 30;36(2):116-21. doi: 10.1038/emm.2004.17. Exp Mol Med. 2004. PMID: 15150439

10

A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma.

Sun JM, Han W, Im SA, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ, Choe KJ, Kim NK. Sun JM, et al. Among authors: noh dy. Cancer. 2004 Dec 1;101(11):2516-22. doi: 10.1002/cncr.20665. Cancer. 2004. PMID: 15517588 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

524 results

Search Page

Filters